trending Market Intelligence /marketintelligence/en/news-insights/trending/94olJeajGywhsuIWAZzxOA2 content esgSubNav
In This List

Reports: CVS reaches $69B deal to buy Aetna

Blog

Using ESG Analysis to Support a Sustainable Future

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings


Reports: CVS reaches $69B deal to buy Aetna

CVS Health Corp. reached a deal to buy Aetna Inc. for about $69 billion in cash and stock, The Wall Street Journal reported Dec. 3, citing sources familiar with the matter.

Under the long-rumored deal, Aetna shareholders will receive $207 a share, including $145 in cash and $62 in stock, according to WSJ sources.

A Dec. 3 Bloomberg news report, citing an unnamed source familiar with the deal, pegged the price tag at $67.5 billion; when accounting for CVS assuming Aetna debt, the deal value would total $78 billion, Bloomberg reported.

The deal is expected to be formally announced later in the day.

Both companies have been in deal talks since October, according to news reports. If approved by federal regulators, the deal would put a chain of retail pharmacies, a pharmacy benefit manager and a healthcare provider under the control of a single company.